Article Information
History
- July 15, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Hiba Dagher1,
- Anne-Marie Chaftari1,*,
- Patricia Mulanovich1,
- Ying Jiang1,
- Ray Hachem1,
- Alexandre E. Malek1,
- Jovan Borjan2,
- George M. Viola1 and
- Issam Raad1
- 1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 2Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- ↵*Corresponding author:
Anne-Marie Chaftari, Department of Infectious Diseases, Infection Control and Employee Health, Unit 1460, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA. Tel: 713-792-3491, Email: achaftari{at}mdanderson.org
Posted July 15, 2022.
Procalcitonin for Antimicrobial Stewardship Among Cancer Patients Admitted with COVID-19
